Pay in 4 interest-free payments of $5.77 Learn more
Ships within 48 hours · Estimated delivery Sep 2 - Sep 7
While metformin remains the first-line treatment for type 2 diabetes, healthcare providers may recommend GLP-1 agonists in various scenarios
Who Should Avoid GLP-1s
We have recovered billions for our clientswith billions more to come
Step 1: Take the Quiz Start by answering a short series of questions about your weight, health history, and previous weight-loss attempts
94% reduction in progression from pre diabetes to type 2 diabetes with tirzepatide.** **Based on a three-year clinical trial study (176-week treatment period) sponsored by Eli Lilly and Company, weekly injections of tirzepatide significantly reduced the risk of progression to type 2 diabetes by 94% in adults with prediabetes who were overweight or obese compared to placebo
GLP-1 medications are a great option for many people, but they aren't right for everyone
US$ 22.42
US$ 23.36
US$ 23.59
US$ 20.29
